Christopher Yea Kal Vista Pharmaceuticals, Inc. (KALV) insider trading activity

Christopher Yea is CHIEF DEVELOPMENT OFFICER of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 223,508 shares of KALV, which is worth approximately $2.98 Million. The most recent transaction as insider was on Nov 01, 2021, when has been sold 5,000 shares (Common Stock) at a price of $18.07 per share, resulting in proceeds of $90,350. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 224K

69.26% 3M change

145.23% 12M change

Total Value Held $2.98 Million

Christopher Yea Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 01 2021	SELL Open market or private sale	$90,350 $18.07 p/Share	5,000 Reduced 13.17%	32,969 Common Stock
Aug 02 2021	SELL Open market or private sale	$102,600 $20.52 p/Share	5,000 Reduced 11.64%	37,969 Common Stock
May 03 2021	SELL Open market or private sale	$124,200 $24.84 p/Share	5,000 Reduced 10.42%	42,969 Common Stock
Feb 23 2021	SELL Open market or private sale	$502,350 $33.49 p/Share	15,000 Reduced 23.82%	47,969 Common Stock
Oct 29 2020	SELL Open market or private sale	$87,400 $17.48 p/Share	5,000 Reduced 7.36%	62,969 Common Stock
Oct 21 2020	SELL Open market or private sale	$110,907 $18.35 p/Share	6,044 Reduced 8.17%	67,969 Common Stock
Oct 20 2020	SELL Open market or private sale	$140,097 $17.64 p/Share	7,942 Reduced 9.69%	74,013 Common Stock

Oct 16 2020	SELL Open market or private sale	$15,538 $17.0 p/Share	914 Reduced 1.1%	81,955 Common Stock

Christopher Yea

CHIEF DEVELOPMENT OFFICER

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALV shares.

Notify only if

Value

Insider Trading

Get notified when an Kal Vista Pharmaceuticals, Inc. insider buys or sells KALV shares.

Notify only if

Operation

Value

Type

News

Receive news related to KalVista Pharmaceuticals, Inc.

Track Activities on KALV

Account